Federal Circuit upholds Howmedica patent ruling

The US Court of Appeals for the Federal Circuit has refused to review an earlier ruling that invalidated a patent owned by Howmedica Osteonics in the company’s dispute with medical device company Zimmer.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Stryker subsidiary settles trade secrets clash with Zimmer

29 November 2017 A subsidiary of medical technology company Stryker has settled its clash over trade secrets with Zimmer, a medical device business.

Americas

Glenmark infringed Bayer’s Finacea patent, says Federal Circuit

18 May 2016 The US Court of Appeals for the Federal Circuit ruled that Glenmark Pharmaceuticals infringed a Bayer Healthcare patent for the rosacea treatment Finacea.

Americas

Polymer patent invalidated by split Federal Circuit

29 February 2016 The US Court of Appeals for the Federal Circuit has invalidated a polymer patent owned by Howmedica Osteonics, reversing an earlier decision from the US Patent and Trademark Office and ending the company’s long running dispute with medical device company Zimmer.

More on this story

Americas

Stryker subsidiary settles trade secrets clash with Zimmer

29 November 2017 A subsidiary of medical technology company Stryker has settled its clash over trade secrets with Zimmer, a medical device business.

Americas

Glenmark infringed Bayer’s Finacea patent, says Federal Circuit

18 May 2016 The US Court of Appeals for the Federal Circuit ruled that Glenmark Pharmaceuticals infringed a Bayer Healthcare patent for the rosacea treatment Finacea.

Americas

Polymer patent invalidated by split Federal Circuit

More on this story

Americas

Stryker subsidiary settles trade secrets clash with Zimmer

29 November 2017 A subsidiary of medical technology company Stryker has settled its clash over trade secrets with Zimmer, a medical device business.

Americas

Glenmark infringed Bayer’s Finacea patent, says Federal Circuit

18 May 2016 The US Court of Appeals for the Federal Circuit ruled that Glenmark Pharmaceuticals infringed a Bayer Healthcare patent for the rosacea treatment Finacea.

Americas

Polymer patent invalidated by split Federal Circuit